Apogee Therapeutics, Inc. · NASDAQ:APGE

Dambkowski Carl sold 5,500 Apogee Therapeutics, Inc. shares (Form 4)

Traded May 6, 2026 · Filed May 8, 2026

On May 6, 2026, Dambkowski Carl (Chief Medical Officer) sold 5,500 Apogee Therapeutics, Inc. shares at an average US$84.14 for US$463K under a trading plan, leaving 207,023 shares. Filed May 8, 2026 (Form 4).

Sold
5,500 shares
Price
US$84.14 average (US$83.92 to US$84.60)
Value
US$463K
Holding after
207,023 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 6, 2026Common StockOption exercise4,125US$22.86212,523Direct
May 6, 2026Common StockSale3,700US$83.92208,823Direct
May 6, 2026Common StockSale1,800US$84.60207,023Direct

Source

View original at SEC

Related